Enfortumab vedotin - intravenous


Patient Medicine Information
Why do I need this medicine?
Enfortumab vedotin is used on its own or together with other medicines to treat cancer of the bladder and the urinary tract.

This medicine is used in individuals who have received previous therapy with other medicines for cancer and whose tumour has spread to other parts of the body.
How do I use this medicine?
Enfortumab vedotin is to be given intravenously (into the vein) as an infusion. It is delivered directly into the bloodstream via the blood vessel.

Your doctor or nurse will administer the injection for you.

The dose of Enfortumab vedotin will be decided by your doctor. Your doctor will advise you on the course of treatment depending on your condition and your response to the medication.
What should I do if I have forgotten to use this medicine?
Ensure that you keep all appointments with your doctor so that you do not miss any doses. Your doctor also needs to regularly monitor your response to Enfortumab vedotin.

If you miss an appointment or miss an injection, alert your doctor or nurse. A replacement appointment or injection should be given as soon as possible.
When should I not use this medicine?
Alert your doctor if you have moderate to severe liver disease as Enfortumab vedotin may not be suitable for you.

Do not use this medicine if you are pregnant or planning to have a baby soon. If you become pregnant while being treated with Enfortumab vedotin, alert your doctor immediately. This medicine may cause harm to your unborn child.

Men should not father a child while being treated with this medicine. Both men and women must use proven birth control methods during Enfortumab vedotin therapy and for at least 12 months (in women) or for up to 9 months (in men) after stopping the treatment. You may wish to discuss reliable methods of birth control with your doctor.

Do not breastfeed while you are being treated with this medicine and for 6 months after the last dose.
What should I take note of while using this medicine?
Inform your doctor if you have high levels of blood sugar or diabetes.

Why is it important to keep my appointments with the doctor?

Keep your appointments with your doctor. Your doctor needs to monitor your condition and check your response to the medication regularly.
  • Pregnancy tests must be done before treatment to know if Enfortumab vedotin is suited for you to use.
  • Routine tests (e.g. complete blood count, liver function, blood sugar levels) may be done while you are being treated with this medicine. Your doctor will advise you about how often you need to have these tests.
  • Regular monitoring for signs or symptoms of lung or eye problems, infusion site reactions, and skin reactions may also be needed.
What side effects could I experience?
Enfortumab vedotin may cause any of the following side effects: nausea, vomiting, constipation, diarrhoea, stomach pain, changes in the sense of taste, mouth ulcers, decreased appetite, weight loss, muscle pain, hair loss, and skin rash or itching.

Some side effects may need immediate medical help. Alert your doctor quickly if you experience any of the following:
  • rashes with peeling of the skin or blistering of the lips, mouth or eyes accompanied by fever
  • increased thirst, frequent urination, confusion, drowsiness, fruity smell of your breath
  • cough, shortness of breath, chest discomfort
  • new or worsening numbness or tingling sensation in the hands or feet, muscle weakness
  • dry eyes, increased tearing, blurred vision
  • pain, redness, swelling, itching or blistering at the infusion site
Inform your doctor if any of these side effects do not go away or are severe, or if you experience other side effects.
Can I use this with other medicines?
Inform your doctor and pharmacist if you are taking medicines any of these medicines:
  • medicines to treat fungal infection e.g. ketoconazole, itraconazole, voriconazole
  • medicines for epilepsy (fits or seizures) e.g. carbamazepine, phenytoin, phenobarbital
  • medicines for HIV infection e.g. ritonavir, nelfinavir, indinavir
  • certain antibiotics e.g. clarithromycin, telithromycin
  • rifampicin (medicine used to treat TB, a lung infection known as tuberculosis)
  • St. John's wort (herbal medicine)
This list does not include all medicines that may interact with Enfortumab vedotin.

Always notify your doctor and pharmacist if you are taking or using any other medicines, including herbal tonics such as traditional Chinese medicines, supplements, and medicines that you buy without a prescription.
What special dietary instructions should I follow?
Avoid alcohol.
How should I store this medicine?
Store in the refrigerator, between 2-8°C. Do not freeze Enfortumab vedotin otherwise, it will no longer be effective and should not be used.

Protect from direct sunlight.

Medicines must not be used past the expiry date.

As this is a cancer medicine, always return any unused or expired medicine to the clinic, hospital, or pharmacy for disposal. Do not throw it away in the household waste.
This information is independently developed by MIMS based on enfortumab vedotin - intravenous and is provided for your reference only. It is not a replacement for and should only be used in conjunction with full consultation with a licensed healthcare professional, the information provided by your pharmacist and/or the manufacturer of the medication. It may not contain all the available information you require and cannot substitute professional medical care, nor does it take into account all individual circumstances. Although great effort has been made to ensure content accuracy, we shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in